Arizona Liver Health’s Post

What a day at #EASLCongress! On top of the bright and sunny day in Milan, two amazing meetings and the MASH data release made my day perfect. No surprises that the EASL Secretary General was at the conference, but what came as a welcome surprise was that we met more as college batchmates rather than industry colleagues. Aleksander Krag, it was like we never lost touch, as we continued from exactly where we left it off many years ago. The only positive difference was that this time, we exchanged notes about how we can collaborate closely to enhance patient outcomes, from our respective positions. The second powerful discussion was with Global Liver Institute. Donna Cryer and Jeff McIntyre, your focus on diversity and patient-friendly design of clinical trials as the starting point to improve access to innovation for patients across the world is in complete alignment with Boehringer Ingelheim’s focus on Health Equity. We should take this discussion forward, and soon – so that we can continue to move the needle ever closer towards inclusive patient solutions. I am confident that we can maximize the access of transformative treatments to liver patients across the world through partnerships amongst #patientadvocates, #healthcare systems, #academia and industry, starting from early screening to diagnosis and prognosis. This is my vision for a truly inclusive treatment+care model that can significantly impact patients’ lives. Let’s do it, together! #LiverDisease #LifeForward EASL | The Home of Hepatology #HealthEquity #ClinicalTrials

Luminesce Alliance celebrates International Clinical Trials Day and the 250th anniversary of the first clinical trial by honoring trial leaders, support teams, and participants. We thank our clinical trial teams and community participants for advancing our health system and enabling new discoveries and treatments. International Clinical Trials Day marks May 20, 1774, when James Lind linked citrus fruits to scurvy prevention. Earlier trials include a 1537 experiment by Ambroise Paré, who treated wounds with a mixture that reduced pain and inflammation. Clinical trials have evolved significantly and are now crucial in modern medicine. How does Luminesce Alliance support clinical trials? We provide financial support for the delivery of clinical trials and professional training opportunities, including webinars and workshops, to enhance workforce capacity and foster connections. #ClinicalTrialsDay #HealthcareInnovation #MedicalResearch

This week, the EC-co-funded DeCODe consortium held its kick-off meeting in Brussels on 9-10 September 2024. This two-year ground-breaking initiative aims to catalyse innovation and address the unique healthcare needs of people living with rare diseases (PLWRD), specifically children. This collaborative consortium, comprising clinicians, researchers, industry experts, and regulatory authorities, will develop a platform for developing safe and effective paediatric and orphan medical devices.  This initiative will support the development of paediatric and orphan devices via two steps. It will map paediatric and orphan stakeholders and initiatives and develop a critical pathway analysis to determine the optimal way to develop novel paediatric and orphan medical technologies. As a next step, DeCODE will select five developers for support via grant applications that are expected to launch in March 2025.  #EU4Health, #UT, #HTSR, #rarediseases, #Medicaldevices With Tom Melvin, Hayley Every, Akvile Zalatoryte, MSc, VBHC Green Belt, Fenna Mahler, Ricardo Fernandes, Prof Dr Wout Feitz, MD, PhD, FEBU, FEAPU., Michelle Battye, Marc Dooms, Isabelle Huys, Vincenzo Carbone, PhD, Annalisa Sechi, Kolaleh Eskandanian, PhD, MBA, PMP, Dr Donal O'Connor, Virginie HIVERT

Super elated to be 1 out of the 15 recipients of GlobalSkin - International Alliance of Dermatology Patient Organizations scholarship to take on the EUPATI Patient Expert Training Program 2025 cohort!! 🙌🏻 Representing psoriatic disease through Psoriasis Indonesia and PsorAsia ⭐️ Many many things to learn to advance patient involvement in medicine research in Asia. #patientadvocacy #psoriaticdisease

The Steering Committee Meeting Materials from Wednesday have been uploaded. Noor Falah, MS thanks so much. Here is the link: https://lnkd.in/eVVS53qt. Also big thanks to everyone for participating: Brandon Gallas S. Joseph Sirintrapun Kevin Schap and so many more. See you next months on April 24th 2024 – 3PM EST If you want to join the community: https://lnkd.in/e-Kec5ZT Briefly, PIcc is a regulatory science initiative that aims to facilitate innovations in pathology as well as advance safety and effectiveness evaluation, and to harmonize approaches to speed delivery to patients using collaborative, pre-competitive approaches. The collaborative community (PIcc) is open to all stakeholders, public or private, including, but not limited to, academia, industry, health care providers, patients and advocacy groups. A collaborative community is a continuing forum in which all stakeholders, public and private, alongside the FDA, work together on regulatory science questions and medical device challenges to achieve common objectives.  The Pathology Innovation Collaborative Community (PIcc) has achieved recognition as a collaborative community with participation by the FDA.  Participation in collaborative communities is one of the FDA’s Center for Devices and Radiological Health’s (CDRH) strategic priorities.  #PathologyInnovationCollaborativeCommunity #PICC Medical Device Innovation Consortium (MDIC)

STI research needs you! If you’re a healthcare provider, you can support STI research by referring your patients to a local research site for clinical trials. If you’re a human person (that’s you!), you can support STI research by participating in clinical trials in your local area. If you’re in the Albuquerque, Santa Fe, El Paso, or Salt Lake City areas, consider joining a trial or referring your patients to trials at AXCES. Learn more by giving us a call at 505-207-8078 or by going to this link: https://lnkd.in/gV6rWAfE #STIAwareness #ClinicalTrials #PublicHealth #ClinicalResearch #STIs #STDs

Happy International Clinical Trials day to my network! Did you know that today marks the day James Lind began what was considered the first randomized clinical trial in 1747.. over 250 years ago! This day serves to recognise and celebrate the vital role that clinical trials play in advancing medical research and improving patient outcomes. It highlights the contributions of researchers, healthcare professionals, and volunteers who participate in these trials, helping to develop new treatments and therapies. Clinical Trials day also aims to raise awareness about the importance of clinical research and encourage public engagement and participation, enabling a greater understanding of how clinical trials contribute to the discovery of life-saving medications and medical procedures 😷 #clinicaltrials #clinicalresearch #global #medicalresearch #medicalwriting #clinicaloperations #regulatoryaffairs #clinicaltrial

🌐 Webinar Recap: Clinical Trial Management in Academic Medical Centers 🌐 We had the pleasure of hosting Dr. Tony Succar in our recent #OCRA-DG webinar! With experience across three major institutions, Tony Succar, PhD, MScMed(OphthSc) shared insights from his work on a bionic eye and a virtual vision rehab program, highlighting the essential role of clinical trials in developing new treatments. Key takeaways: 🔹 Over 500,000 trials registered on ClinicalTrials. gov underscore the need for effective trial management. 🔹 Strategies for participant retention, managing drug vs. device trials, and the unique challenges of pediatric trials. 🔹 Practical tips for improving trial success and participant experience. 📅 Looking ahead to 2025: #Join OCRA to access our exclusive webinars all year long and stay ahead! https://lnkd.in/gBeUJtGc #ClinicalTrials #WebinarRecap #JoinOCRA #ProfessionalDevelopment

🔍💊💉𝐁𝐮𝐬𝐭𝐢𝐧𝐠 𝐌𝐲𝐭𝐡𝐬 #𝟓: 𝐂𝐨𝐧𝐜𝐞𝐫𝐧𝐞𝐝 𝐚𝐛𝐨𝐮𝐭 𝐫𝐞𝐜𝐞𝐢𝐯𝐢𝐧𝐠 𝐚 𝐩𝐥𝐚𝐜𝐞𝐛𝐨 𝐢𝐧 𝐚 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥? 🧐 Dr. Junie Khoo clarifies: participants are fully informed and never receive placebos alone. Learn more about the realities of clinical trials. ➡️To learn more about clinical trials, kindly visit: https://lnkd.in/gkTZczhU 📱Call us to make an appointment at: +603-71187878 or https://wa.link/svj6e0 #BeaconHospital #agoodhospital #MythBusting #Myths #Truths #ClinicalTrials #ClinicalResearch #Research #PatientSafety #PatientRights #HealthFacts #NewTreatment #CancerTreatment

Exciting Breakthrough in Pressure Ulcer Treatment! 🌟 We are thrilled to share the results of the R.I.S.E. U.P. Study, a groundbreaking clinical trial evaluating the effectiveness of the EmoLED medical device in treating stage II and III pressure ulcers. This study is the first randomized clinical trial demonstrating the power of Photobiomodulation with Blue Light! ✅ The results? A 76% greater reduction in PUSH scores for patients treated with EmoLED compared to conventional therapy. ✅ 97.2% of patients treated with EmoLED showed significant wound improvement, compared to only 56.1% in the control group https://lnkd.in/gEdUdF3n